Shows
Retro SpectivesE136: Warcraft II: Tides of DarknessWarcraft II is one of the most influential RTS games of all time. It brought the genre to the mainstream with insane sales, and set the standard for UI and tech trees for years to come. Blizzard had cracked the code on what made RTS games tick, and it laid the groundwork for the classics that would come in its wake.But for all its influence, how much fun is Warcraft II to actually play today? Does it suffer from its far more simplistic mechanics and mirrored factions, or is there something elegant and refined about a mor...
2025-12-231h 25
Mont Wealth - "Pizz-Spectives"Why AI’s Growth Story Is Real — And Only Getting Started. We talk to Jonon Knight from HyperionIn this episode of Pizz-Spectives, Rob Pizzichetta (Founder, Mont Wealth) sits down with Jolon Knight, Portfolio Manager at Hyperion Asset Management, to unpack one of the most important themes shaping markets today — artificial intelligence (AI) and the global growth opportunity.
Hyperion has built a reputation for finding the world’s elite businesses — the top 1% of companies able to sustain strong returns and earnings growth through cycles. In this conversation, Jolon explains:
✅ Why AI is not another dot-com bubble, but backed by real earnings and adoption.
✅ How Hyperion is positio...
2025-09-0522 min
OncLive® On AirOncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for MelanomaThis Oncology PER®Spectives™ podcast examines the recent advancements in the treatment landscape for advanced melanoma. In this activity, experts Yana Najjar, MD; Rahul A. Sheth, MD, FSIR; and Douglas Johnson, MD, MSCI, discuss the challenges of immune checkpoint inhibitor resistance and the practical strategies for overcoming this by using direct intratumoral injections of oncolytic viral immunotherapies, which rely on close interdisciplinary collaboration between medical oncologists and interventional radiologists.
2025-06-0254 min
OncLive® On AirOptimizing Today and Looking to Tomorrow in Metastatic CRPC - Homing in on EZH2This Oncology PER®Spectives™ podcast explores the role of EZH2 in metastatic castration-resistant prostate cancer (mCRPC) progression and its synergy with androgen receptor inhibitors. In this podcast, experts Neeraj Agarwal, MD, FASCO; Himisha Beltran, MD; and Maha Hussain, MD, FACP, FASCO, discuss the management of mCRPC.
Acknowledgment of Educational Grant Support
This activity is supported by an educational grant from Pfizer Inc.
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, desi...
2025-05-1443 min
OncLive® On AirIncorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLCThis PER® Spectives™ featured podcast reviews the 22nd Annual Winter Lung Cancer Conference® held in January/February 2025. Multiple successive generations of ALK inhibitors have provided increasing benefits as first-line treatment for the thousands of patients with non-small cell lung cancer (NSCLC) that harbors rearrangements or mutations in the ALK gene. This program focuses on the practical aspects of managing patients with ALK-positive advanced or metastatic NSCLC, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
2025-04-1644 min
PER SpectivesPER®Spectives: Advancing Treatment in nAMD and DME with Novel TherapiesThis PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for patients with DME — in the clinical setting.
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
2024-02-0118 min
PER SpectivesPostpartum Depression: A Multidisciplinary Approach to ManagementThis podcast explores the diagnosis and management of postpartum depression with a focus on the importance of screening all postpartum women and treatment options. Two faculty, Sarah Nagle-Yang, MD, and Lindsey Lebin, MD, discuss the importance of an early diagnosis with each other, and a patient shares her journey living with postpartum depression.
Faculty
Lindsay Lebin, MD
Assistant Professor
Department of Psychiatry
University of Colorado School of Medicine
Aurora, CO
Sarah Nagle-Yang, MD
Deputy Executive Director
Colorado Center for Women’s Behavioral Health
University of Colorado Sc...
2023-12-2011 min
PER SpectivesPatient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative TreatmentThis podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy. Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia.
Faculty
Hanny Al-Samkari, MD
Classical Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Kevin H.M. Kuo, MD, MSc, FRCPC
Clinician-Investigator and Clinical Lead
Red Blood Cell D...
2023-12-2035 min
PER SpectivesGeneralized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and ManagementThis podcast features engaging commentary from experts in the clinical management of generalized myasthenia gravis— James Howard, Jr, MD and Nicholas Sylvestri, MD. These experts discuss the burden of disease associated with the disorder, its pathogenesis in terms of the complement system, and the clinical considerations for incorporating appropriate targeted therapy to improve health-related outcomes. Emphasis is placed on the interpretation of recently published or presented data regarding anti-complement therapies. The exerts provide key take-home points and pearls for practice.
Nicholas J. Silvestri, MD
Professor of Neurology
University at Buffalo Jacobs School of Medicine and Biomedical Sci...
2023-12-0521 min
PER SpectivesAdvances in Topical Treatment for PresbyopiaThis PER®Spectives™ podcast examines treatment of presbyopia with a focus on new and emerging topical therapies. In this podcast, experts Mile Brujic, OD, FAAO, and Jay Pepose, MD, PhD, describe these agents and how to select patients with presbyopia who will benefit from topical treatment.
Faculty:
Mile Brujic, OD, FAAO
Premier Vision Group
Bowling Green, OH
Jay Pepose M.D., Ph.D.
Pepose Vision Institute
Chesterfield, MO
2023-08-3124 min
PER SpectivesMultidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease CareOptometrists play a critical role in first-line screening and monitoring of patients with neovascular age-related macular degeneration (or nAMD) and diabetic macular edema (or DME). Where patients require more advanced care, optometrists refer them to retina specialists. Join Drs Ferhina Ali, Carl Regillo, Jessica Steen and Mohammad Rafieetary as they review the role of optometrists in managing retina disease, the role of OCT in the diagnosis and monitoring of retina disease, and the circumstances where patients with retina disease require referral.
Faculty
Carl D. Regillo, MD, FACS
Retina Surgeon
Philadelphia, PA
Mohammad...
2023-08-3027 min
PER SpectivesClinical Pearls in Co-Managing GlaucomaThis PER® Spectives™ featured podcast examines the important role of co-management of glaucoma between optometrists and ophthalmologists .Expert faculty review the selection of traditional and novel topical therapies, and also patient selection for micro-incisional glaucoma surgery (MIGS).
Faculty
Danica J. Marrelli, OD, FAAO, AAO
College of Optometry, University of Houston
Houston, TX
Alena Reznik, MD
Glaucoma Care Center
Newport Beach, CA
2023-08-1612 min
PER SpectivesAdvances in Treatment for Geographic AtrophyThis podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Faculty
David S. Boyer, MD
Retina-Vitreous Associates Medical Group
Los Angeles, CA
Tina Mac Donald, OD, CDCES, FAAO
WesternU Health Los Angeles
Los Angeles, CA
Leo Semes, OD, FAAO
The University of Alabama at Birmingham
Birmingham, AL
2023-08-1428 min
Optometric Insights MediaThe OI Show: Dr. Walt Whitley: What’s New in MGD Beyond Heating and Squeezing?Send us a textThanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below.Activity OverviewThis PER® Spectives™ podcast features a discussion among 3 optometrists on challenges and unmet needs associated with traditional treatments for meibomian gland dysfunction (MGD)-related dry eye disease (DED) — and opportunities for MGD treatment that may come with new and emerging topical therapies. In addition, the panel discusses myths and misconceptions that may affect outcomes in patients with MGD-DED. This program is de...
2023-08-0718 minOptometric Insights MediaThe OI Show: The Ins and Outs of Lubricating Eye Drops with Dr. Selina McGeeSend us a textThanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below.Activity OverviewThis PER® Spectives™ podcast features a discussion among 3 optometrists on concerns related to the use of preserved eye lubricants for patients with dry dye disease. In addition, the panel discusses developments in components within these products to support the ocular surface, including trehalose and hyaluronic acid. This program is designed to help clinicians better match specific eye lubrication products to ind...
2023-07-3114 min
PER SpectivesLooking at the Lid – Reducing Patient Burden in Blepharoptosis & Demodex BlepharitisWelcome to a podcast based on learning about the lid: optimizing recognition, diagnosis, and treatment of Demodex Blepharitis and Blepharoptosis. In this podcast, we will hear from Dr Mile Brujic and Dr Cecelia Koetting.
Faculty
Mile Brujic, OD, FAAO
Partner
Premier Vision Group
Bowling Green, OH
Cecelia Koetting, OD, FAAO, DipABO
Optometrist
Denver, CO
2023-07-1814 min
PER SpectivesThyroid Eye Disease: The Masquerading Eye Disorder - A Guide to Accurate Diagnosis & Collaborative CareIn this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.
Faculty
Steven Leibowitz, MD
Associate Clinical Professor, Oculoplastics and Orbit
Jules Stein Eye Institute
UCLA School of Medicine
Los Angeles, CA
Raymond Douglas, MD, PhD
Clinical Professor of Ophthalmology
Jules Stein Eye Institute
UCLA School of Medicine
Los Angeles, CA
Selina McGee OD, FAAO
CEO/Owner BeSpoke Vision
2023-07-1125 min
PER SpectivesConsiderations for Customizing Care Plans for Patients with Parkinson Disease PsychosisIn this podcast, two experts discuss the diagnosis and treatment of Parkinson disease psychosis. In their conversation, they discuss examples of patients they have encountered. They also discuss the results of recent clinical trials of new therapies and the importance of a multispecialty approach for these patients.
Faculty
Gus Alva, MD, DFAPA
Medical Director, Senior Brain Health
Hoag Hospital
Assistant Professor of Psychiatry and Neuroscience
University of California, Riverside
Medical Director
ATP Clinical Research
Costa Mesa, CA
Stuart Isaacson, MD
Director
Parkinson’s Disease and Mo...
2023-07-0730 min
PER SpectivesCatching and Addressing Early Neurotropic Keratitis: New PerspectivesNeurotrophic keratitis (NK) is a rare condition caused by trigeminal nerve damage, which results in decreased or absent corneal sensitivity and breakdown of the corneal epithelium. If not recognized and managed appropriately, it can lead to corneal ulceration and loss of vision. However, early diagnosis and treatment can improve outcomes.
This featured podcast includes an interview with an optometrist that highlights key considerations in diagnosing NK at an early stage and treating it with traditional and emerging therapies.
Faculty
Walter Whitley, OD, MBA, FAAO
Director of Professional Relations and Education
Regional...
2023-06-2614 min
Get Lost In The Full Audiobook Everyone Is Talking About — So Next-Level!The Power Code: More Joy. Less Ego. Maximum Impact for Women (and Everyone). by Claire Shipman, Katty KayPlease visithttps://thebookvoice.com/podcasts/1/audiobook/636371to listen full audiobooks.
Title: The Power Code: More Joy. Less Ego. Maximum Impact for Women (and Everyone).
Author: Claire Shipman, Katty Kay
Narrator: Sandy Rustin, Katty Kay, Claire Shipman
Format: Unabridged Audiobook
Length: 9 hours 25 minutes
Release date: June 13, 2023
Genres: Management & Leadership
Publisher's Summary:
Power is not working—for women, for men, or for the world. We don’t need to remake women. We need to remake power. New York Times bestselling authors Katty Kay and Claire Shipman are on a mission to reclaim power for women. In the wake of sweeping changes in the...
2023-06-139h 25Download Incredible Full Audiobooks in Business & Economics, Management & LeadershipThe Power Code: More Joy. Less Ego. Maximum Impact for Women (and Everyone). by Claire Shipman, Katty KayPlease visithttps://thebookvoice.com/podcasts/1/audiobook/636371to listen full audiobooks.
Title: The Power Code: More Joy. Less Ego. Maximum Impact for Women (and Everyone).
Author: Claire Shipman, Katty Kay
Narrator: Sandy Rustin, Katty Kay, Claire Shipman
Format: Unabridged Audiobook
Length: 9 hours 25 minutes
Release date: June 13, 2023
Genres: Management & Leadership
Publisher's Summary:
Power is not working—for women, for men, or for the world. We don’t need to remake women. We need to remake power. New York Times bestselling authors Katty Kay and Claire Shipman are on a mission to reclaim power for women. In the wake of sweeping changes in the...
2023-06-139h 25
PER SpectivesFacing the Changing Landscape for Neuromodulators and Dermal Fillers
Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below.
This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in the number of products available for health care providers to use. In this podcast, faculty member Joshua Zeichner, MD, describes these 2 classes of agents and their uses, alone and in combination. He does this by answering questions that are frequently asked by dermatology health care professionals.
Accreditation/Credit Desi...
2023-02-1524 min
PER SpectivesAddressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis
Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below.
This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care, insurance costs, and unintended bias are just some of the factors that contribute to the existence and persistence of these disparities. This program is designed to help clinicians better recognize and take steps to address ethnic and racial disparities, as well as social and economic inequities, in CF...
2023-02-0358 min
PER SpectivesMGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment ParadigmMeibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for treating MGD may ultimately provide new treatment alternatives.
This podcast episode provides a review of some of the key highlights from a live symposium held during the American Academy of Optometry Annual Meeting 2022 in October.
Faculty
2023-01-3118 min
PER SpectivesAdvances in Sickle Cell Disease ManagementThis podcast features engaging commentary from experts in the clinical management of patients with sickle cell disease: Nirmish Shad, MD from Duke University Medical Center, Matthew Heeney, MD Matthew Heeney, MD from Harvard Medical School, and Charles R. Jonassaint, PhD, MHS from University of Pittsburgh School of Medicine. These experts review clinical guidelines, interpret clinical data regarding current and emerging therapeutics for sickle cell disease, share best practices for addressing psychosocial health needs and helping pediatric patients transition to adult care.
2023-01-3129 min
PER SpectivesPart 1 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Dara Aisner MD, PhDOur ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available or undergoing late-stage evaluation that target genomic alterations and biomarkers, including EGFR, MET, HER3, NRG1, HER2, TROP2, ROS1, KRAS, NTRK, and RET.
This featured podcast includes interviews with some of the field’s top experts on where we are in terms of testing, safety and...
2022-08-1718 minPER SpectivesPart 2 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with David Gandara MDOur ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available or undergoing late-stage evaluation that target genomic alterations and biomarkers, including EGFR, MET, HER3, NRG1, HER2, TROP2, ROS1, KRAS, NTRK, and RET.
This featured podcast includes interviews with some of the field’s top experts on where we are in terms of testing, safety and...
2022-08-1707 minPER SpectivesPart 3 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Charu Aggarwal MD, MPHOur ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available or undergoing late-stage evaluation that target genomic alterations and biomarkers, including EGFR, MET, HER3, NRG1, HER2, TROP2, ROS1, KRAS, NTRK, and RET.
This featured podcast includes interviews with some of the field’s top experts on where we are in terms of testing, safety and...
2022-08-1706 minPER SpectivesPart 4 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Julia Rotow MDOur ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available or undergoing late-stage evaluation that target genomic alterations and biomarkers, including EGFR, MET, HER3, NRG1, HER2, TROP2, ROS1, KRAS, NTRK, and RET.
This featured podcast includes interviews with some of the field’s top experts on where we are in terms of testing, safety and...
2022-08-1717 minPER SpectivesPart 5 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Balazs Halmos MD, MSOur ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available or undergoing late-stage evaluation that target genomic alterations and biomarkers, including EGFR, MET, HER3, NRG1, HER2, TROP2, ROS1, KRAS, NTRK, and RET.
This featured podcast includes interviews with some of the field’s top experts on where we are in terms of testing, safety and...
2022-08-1710 min
PER SpectivesTumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast CancerDuring this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer.
Featuring:
Fátima Cardoso, MD
Director, Breast Unit
Champalimaud Clinical Center
Lisbon, Portugal
Mario Campone, MD, PhD
Chief Executive Officer
Institut de Cancérologie de l’Ouest (ICO)
Angers, France
Giuseppe Viale, MD, FRCPath
Chairman
Department of Pathology
University of Milan
Milan, Italy
2022-07-0649 min
PER SpectivesManaging Your Patients with CKDDr. Eden Miller and Kim Zuber, PA-C, discuss the importance of screening patients with chronic kidney disease (CKD) for comorbidities and treating them early. They also discuss the treatment options available among both current and emerging classes of therapies and across different clinical subspecialties. After you listen to this podcast, go to https://www.gotoper.com/2022consckd to learn more and get CME credit!
Featuring:
Eden Miller, DO
High Lakes Health Care Sisters
Sisters, OR
Kim Zuber, PA-C
Executive Director, American Academy of Nephrology Physician Assistants
St. Petersburg, FL
2022-04-1945 min
Embrace This Ground-Breaking Full Audiobook — Perfect Before Bedtime.Design for Belonging: How to Build Inclusion and Collaboration in Your Communities by Susie WisePlease visithttps://thebookvoice.com/podcasts/1/audiobook/548788to listen full audiobooks.
Title: Design for Belonging: How to Build Inclusion and Collaboration in Your Communities
Author: Susie Wise
Narrator: Susie Wise
Format: Unabridged Audiobook
Length: 3 hours 23 minutes
Release date: April 19, 2022
Genres: Career Development
Publisher's Summary:
A practical, illustrated guide to using the tools of design to create feelings of inclusion, collaboration, and respect in groups of any type or size—a classroom, a work team, an international organization—from Stanford University's d.school. “This is a beautiful book. Wise has applied the gift and imagination and lenses of the d.school to one of...
2022-04-193h 23Dive Into A Full Audiobook That Is Simply Next-Level.Design for Belonging: How to Build Inclusion and Collaboration in Your Communities by Susie WisePlease visithttps://thebookvoice.com/podcasts/1/audiobook/548788to listen full audiobooks.
Title: Design for Belonging: How to Build Inclusion and Collaboration in Your Communities
Author: Susie Wise
Narrator: Susie Wise
Format: Unabridged Audiobook
Length: 3 hours 23 minutes
Release date: April 19, 2022
Genres: HR & Admin
Publisher's Summary:
A practical, illustrated guide to using the tools of design to create feelings of inclusion, collaboration, and respect in groups of any type or size—a classroom, a work team, an international organization—from Stanford University's d.school. “This is a beautiful book. Wise has applied the gift and imagination and lenses of the d.school to one of...
2022-04-193h 23Get Top Full Audiobooks in Business & Economics, HR & AdminDesign for Belonging: How to Build Inclusion and Collaboration in Your Communities by Susie WisePlease visithttps://thebookvoice.com/podcasts/1/audiobook/548788to listen full audiobooks.
Title: Design for Belonging: How to Build Inclusion and Collaboration in Your Communities
Author: Susie Wise
Narrator: Susie Wise
Format: Unabridged Audiobook
Length: 3 hours 23 minutes
Release date: April 19, 2022
Genres: HR & Admin
Publisher's Summary:
A practical, illustrated guide to using the tools of design to create feelings of inclusion, collaboration, and respect in groups of any type or size—a classroom, a work team, an international organization—from Stanford University's d.school. “This is a beautiful book. Wise has applied the gift and imagination and lenses of the d.school to one of...
2022-04-193h 23Get Best Full Audiobooks in Self-Improvement, Career DevelopmentDesign for Belonging: How to Build Inclusion and Collaboration in Your Communities by Susie WisePlease visithttps://thebookvoice.com/podcasts/1/audiobook/548788to listen full audiobooks.
Title: Design for Belonging: How to Build Inclusion and Collaboration in Your Communities
Author: Susie Wise
Narrator: Susie Wise
Format: Unabridged Audiobook
Length: 3 hours 23 minutes
Release date: April 19, 2022
Genres: Career Development
Publisher's Summary:
A practical, illustrated guide to using the tools of design to create feelings of inclusion, collaboration, and respect in groups of any type or size—a classroom, a work team, an international organization—from Stanford University's d.school. “This is a beautiful book. Wise has applied the gift and imagination and lenses of the d.school to one of...
2022-04-193h 23
PER SpectivesWhat You Need to Know About the Evolving Role of TIL Therapy in Cancer TreatmentTumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will break down what the community physician needs to know about this emerging therapy as it makes it’s way out of clinical trials and into the clinic.
Featuring:
Omid Hamid, MD
Cedars-Sinai CANCER
Los Angeles, CA
2022-04-0423 minRetro SpectivesEpisode 68: PikminWe return once more to the strange and esoteric world of console RTS games with Pikmin! First released for the Gamecube in 2001, it combines strategy, resource management and puzzle solving into a truly unique game. You play as Captain Olimar, peacefully vacationing in space until an asteroid collides with his spaceship. He crashes to the ground, pieces of his ship scattering across the land, and no apparent way to get them back to repair his ship. Luckily for him the Pikmin are more than willing to be turned into slave labour to retrieve all those missing parts and murder the...
2021-08-161h 15Retro SpectivesEpisode 57: Streets of Rage 2Pat and James are joined by special guest Drew Koscelek of the WDGR Podcast to discuss and argue whether Streets of Rage 2 has truly stood the test of time. When it was first released in 1992 for the Sega Genesis, it blew everyone away with its gorgeous graphics, vibrant soundtrack, and its fast and fluid gameplay. Even today, many consider it to be one of the best in its genre.Beat ‘em ups were hugely popular in the late 80s and early 90s, a fixture of the arcade scene and dominating the home console market in the early 90s. ...
2021-03-151h 41Retro SpectivesEpisode 53: Civilization IV: Beyond the SwordThe Civilization series is one of the most consistently successful 4x titles throughout video game history. It saw its first entry way back in 1991, and would continue to refine its history spanning empire building over the years. Perhaps the most well regarded of them was Civilization IV: Beyond The Sword, a standalone expansion pack for Civ IV that promised the deepest and most complex strategy up to that date.Civilisation V, however, seemed to break from a lot of what defined the main series up to that point. Unit stacking, global happiness and the removal/replacement of the...
2021-01-181h 34
Justin AnswerBorrowing Success?When you “borrow” success approaches from OUTSIDE your industry—approaches none of your competition even knows about, let alone uses—it can give you explosive performance improvement AND preemptive competitive advantage. Profits can actually double, redouble, even double again—realistically (and easier) than you can imagine with the same or less effort. Pit your competitors against THIS “Positive Intimidation Factor” and your business can win every time!
I take multiple success approaches from outside a given industry and combine many together into powerhouse, fresh “hybrids” that create the newfound profit power for each of my clients.
MASTERFUL THINKING PARTNER. This means my contr...
2019-11-1104 min